Read more here
Apodan A/S has recently established a cooperative venture with Biosynex SA to introduce their new 10-minute COVID-19 finger prick antibody test of the accuracy of which matches formal laboratory blood testing. A French publicly listed company we are launching their newly developed antibody test called BIOSYNEX COVID-19 BSS (IgG/IgM). It provides unrivalled accuracy as well as the independent detection of both IgM and IgG and thus provides an accurate and complete test of immunity. It does this with a simple finger prick, in a test that can potentially be self-administered by the patient, and which reads out in just 10 minutes. No needles, syringes, specialists, hospitals, laboratories, queues, follow-up visits or days spent waiting for the reports are required.
This COVID-19 antibody test demonstrates uniquely high sensitivity and specificity – no uncertain test results. The antibody test has undergone thorough validation at leading international institutes, including the renowned Pasteur Institute. There are no products like it on the market and it compares favourably with any full-blown blood test. Yet, results is available in 10 minutes!
Apodan A/S has chosen this product due to its superb quality and supply reliability from the Biosynex S/A facility in Strasbourg, France.
The tests are easily carried out by a pharmacist, nurse or GP. A self-test will be available very soon.
We are the first company to bring reliable testing to communities, companies and families alike.
Our Core Story
Apodan is a purpose-driven Danish company that develops and sells products to healthcare professionals and patients in the Danish and international health sector.
The idea of making a difference drives us, and we are making an effort to contribute to a real improvement in our user's health and quality of life.
It may sound like pure philanthropy, but nearly 60 years in the industry have shown us that it is, fortunately, an excellent business for both producer, citizen and society to invest in improved health.